Urology · Midland Park, NJ
NPI
1376679639
Since 2007
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4 Godwin Avenue
Midland Park, NJ, 07432
Phone (201) 444-7070
Groups this clinician bills Medicare through
Medicare paid, 2024
$741K
18,077 services
Medicare patients, 2024
1,428
Average age 79
Drug cost, 2024
$1.3M
4,559 prescriptions
Company payments, 2025
$431
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Victor Hartanto was code J0585 (injection, onabotulinumtoxina, 1 unit), 4,100 times for 21 patients. In total Victor Hartanto billed 18,077 services in 93 codes, and Medicare paid $741K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 4,100 | 21 | $4.97 | $20K |
| 81000 Clinical Chemistry | Office | 2,200 | 1,160 | $3.94 | $8,668 |
| 99213 Office E&M - Established | Office | 1,565 | 961 | $73.40 | $115K |
| 76857 Ultrasound - Abdomen and Pelvis | Office | 1,520 | 958 | $41.58 | $63K |
| 99214 Office E&M - Established | Office | 705 | 488 | $105.85 | $75K |
| 96372 Injection Administration | Office | 610 | 409 | $12.25 | $7,472 |
| 36415 Venipuncture Blood Collection | Office | 434 | 274 | $8.65 | $3,754 |
| 84153 Clinical Chemistry | Office | 422 | 272 | $18.02 | $7,604 |
| J3260 Injection, tobramycin sulfate, up to 80 mg | Office | 421 | 335 | $1.83 | $772 |
| 51798 Ultrasound - Nonspecific | Office | 289 | 165 | $9.60 | $2,775 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 274 | 241 | $93.42 | $26K |
| J1580 Injection, garamycin, gentamicin, up to 80 mg | Office | 272 | 120 | $1.87 | $508 |
| 84154 Clinical Chemistry | Office | 231 | 150 | $18.02 | $4,163 |
| 82270 Immunoassay | Office | 200 | 200 | $4.29 | $858 |
| 99204 Office E&M - New | Office | 189 | 188 | $132.06 | $25K |
By year: 2022 $755K for 20,602 services; 2023 $688K for 18,027 services; 2024 $741K for 18,077 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81000 Clinical Chemistry | 2,200 | 1,160 | $3.94 | $8,668 |
| 36415 Venipuncture Blood Collection | 434 | 274 | $8.65 | $3,754 |
| 84153 Clinical Chemistry | 422 | 272 | $18.02 | $7,604 |
| 84154 Clinical Chemistry | 231 | 150 | $18.02 | $4,163 |
| 82270 Immunoassay | 200 | 200 | $4.29 | $858 |
| 81002 Clinical Chemistry | 40 | 40 | $3.41 | $136 |
| 84403 Clinical Chemistry | 36 | 19 | $25.29 | $910 |
Medicare prescription drug claims, 2024
In 2024, the drug Victor Hartanto prescribed most often to Medicare patients was Myrbetriq (Mirabegron), with 812 prescriptions and refills. In total Victor Hartanto wrote 4,559 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Myrbetriq Mirabegron | 812 | 1,553 | 212 | $695K |
| Tamsulosin Hcl Generic | 727 | 2,014 | 227 | $17K |
| Cefuroxime Cefuroxime Axetil | 455 | 896 | 220 | $8,801 |
| Silodosin Generic | 452 | 1,212 | 142 | $50K |
| Estradiol Generic | 402 | 1,034 | 165 | $38K |
| Gemtesa Vibegron | 361 | 720 | 87 | $336K |
| Finasteride Generic | 161 | 456 | 48 | $2,989 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 135 | 294 | 60 | $951 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 110 | 214 | 43 | $2,585 |
| Ciprofloxacin Hcl Generic | 103 | 139 | 81 | $841 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 86 | 86 | 77 | $1,081 |
| Cephalexin Generic | 78 | 114 | 21 | $721 |
| Methenamine Hippurate Generic | 65 | 127 | 21 | $3,832 |
| Doxycycline Hyclate Generic | 59 | 100 | 32 | $2,077 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 57 | 58 | 32 | $803 |
Brand drugs: - claims; generic drugs: 3,266 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Victor Hartanto $431 ($431 in general payments such as food, travel and fees) from 7 companies. The largest payer was Profound Medical Corp. with $156.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.